DrugPatentWatch Database Preview
CONZIP Drug Profile
» See Plans and Pricing
When do Conzip patents expire, and when can generic versions of Conzip launch?
Conzip is a drug marketed by Cipher Pharms Inc and is included in one NDA. There is one patent protecting this drug.
This drug has three patent family members in three countries.
The generic ingredient in CONZIP is tramadol hydrochloride. There are thirty-six drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the tramadol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Conzip
A generic version of CONZIP was approved as tramadol hydrochloride by SUN PHARM INDS INC on June 19th, 2002.
Summary for CONZIP
| International Patents: | 3 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 74 |
| Clinical Trials: | 1 |
| Patent Applications: | 1,642 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for CONZIP |
| What excipients (inactive ingredients) are in CONZIP? | CONZIP excipients list |
| DailyMed Link: | CONZIP at DailyMed |
Recent Clinical Trials for CONZIP
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Medical College of Wisconsin | Phase 2 |
Pharmacology for CONZIP
| Drug Class | Opioid Agonist |
| Mechanism of Action | Full Opioid Agonists |
US Patents and Regulatory Information for CONZIP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cipher Pharms Inc | CONZIP | tramadol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 022370-001 | May 7, 2010 | RX | Yes | Yes | Get Started for $10 | Get Started for $10 | Y | Get Started for $10 | |||
| Cipher Pharms Inc | CONZIP | tramadol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 022370-003 | May 7, 2010 | RX | Yes | No | Get Started for $10 | Get Started for $10 | Y | Get Started for $10 | |||
| Cipher Pharms Inc | CONZIP | tramadol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 022370-004 | Aug 1, 2011 | DISCN | Yes | No | Get Started for $10 | Get Started for $10 | Get Started for $10 | ||||
| Cipher Pharms Inc | CONZIP | tramadol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 022370-002 | May 7, 2010 | RX | Yes | No | Get Started for $10 | Get Started for $10 | Y | Get Started for $10 | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for CONZIP
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2004110410 | Get Started for $10 |
| Canada | 2495463 | Get Started for $10 |
| Australia | 2002337967 | Get Started for $10 |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for CONZIP
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0566709 | C300152 | Netherlands | Get Started for $10 | PRODUCT NAME: TRAMADOLI HYDROCHLORIDUM EN PARACETAMOLUM; NAT. REGISTRATION NO/DATE: RVG 28113 20030115; FIRST REGISTRATION: 359 228-3 2002050405 |
| 0566709 | SPC/GB04/012 | United Kingdom | Get Started for $10 | PRODUCT NAME: TRAMADOL HYDROCHLORIDE, PARACETAMOL; REGISTERED: FR NL 25970 20020405; UK PL 00242/0384 20030925 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
